文献速递肾移植血液净化与透析

新冠疫情时代肾移植与继续等待名单的死亡风险比较

Informing the Risk of Kidney Transplantation Versus Remaining on the Waitlist in the Coronavirus Disease 2019 Era.
PubMed 文献 · Kidney Int Rep · 2020-11-05

该研究基于1433例终末期肾病患者队列,比较了299例等待名单患者与237例移植后第一年受者的COVID-19感染率和结局。随访68天发现,等待名单患者感染率更高,但移植受者确诊后死亡风险更高(校正后HR=3.36,95%CI 1.19-9.50,P=0.022),两组总体死亡率相当(P=0.69)。

要点

  • 等待名单患者COVID-19感染率更高,但移植受者感染后死亡风险更高。
  • 两组总体死亡率相当,移植受者确诊后死亡风险校正后HR为3.36。
  • 透析患者未检测感染血清阳性率18.3%,移植受者4.6%。

核心结论

  • 等待名单患者COVID-19感染更常见,但移植受者感染相关死亡率更高,导致总体死亡率相当。

研究设计与样本

  • 回顾性队列研究,纳入1433例终末期肾病患者,分析299例等待名单患者与237例移植后第一年受者,随访68天。

主要发现

  • 等待名单与移植受者总体死亡率相当(P=0.69)。
  • 等待名单患者COVID-19感染诊断更常见(P=0.001),且更可能接受RT-PCR检测(P=0.0004)。
  • 确诊感染后,移植受者死亡风险更高(P=0.015)。
  • 透析与移植患者中未检测感染的血清阳性率分别为18.3%和4.6%(P=0.0001)。
  • 校正筛查偏倚后,移植受者确诊COVID-19后死亡相对风险仍更高(HR=3.36,95%CI 1.19-9.50,P=0.022)。

临床怎么用

  • 在COVID-19流行期,应权衡移植受者感染后高死亡风险与等待名单患者感染风险,个体化决策。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

INTRODUCTION: There are limited data pertaining to comparative outcomes of remaining on dialysis versus kidney transplantation as the threat of coronavirus disease 2019 (COVID-19) remains. In this study we delineate the differential risks involved using serologic methods to help define exposure rates. METHODS: From a cohort of 1433 patients with end-stage kidney disease (ESKD), we analyzed COVID-19 infection rates and outcomes in 299 waitlist patients compared with 237 transplant recipients within their first year post-transplant. Patients were followed over a 68-day period from the time our transplant program closed due to COVID-19. RESULTS: The overall mortality rates in waitlist and transplant populations were equivalent (P = 0.69). However, COVID-19 infection was more commonly diagnosed in the waitlist patients (P = 0.001), who were more likely to be tested by reverse transcriptase polymerase chain reaction (P = 0.0004). Once infection was confirmed, mortality risk was higher in the transplant patients (P = 0.015). The seroprevalence in dialysis and transplant patients with undetected infection was 18.3% and 4.6%, respectively (P = 0.0001). After adjusting for potential screening bias, the relative risk of death after a diagnosis of COVID-19 remained higher in transplant recipients (hazard ratio = 3.36 [95% confidence interval = 1.19-9.50], P = 0.022). CONCLUSIONS: Although COVID-19 infection was more common in the waitlist patients, a higher COVID-19‒associated mortality rate was seen in the transplant recipients, resulting in comparable overall mortality rates.

来源:Kidney Int Rep,查看原文。版权归原作者所有。

引用

  1. Clarke C, Lucisano G, Prendecki M, et al. Informing the Risk of Kidney Transplantation Versus Remaining on the Waitlist in the Coronavirus Disease 2019 Era. Kidney Int Rep. 2020. PMID: 33173838. doi:10.1016/j.ekir.2020.10.032

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。